Paige Meester
Nurse Practitioner · Sioux Falls, SDNPI 1215446802
Payments from drug & device makers
Across 119 payments — averaging $13.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- E.r. Squibb & Sons, L.L.C.$358
- Johnson & Johnson$308
- AstraZeneca$187
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$165
- Actelion Pharmaceuticals US, Inc.$113
- Amarin Pharma, Inc.$62
- plus $415 from 14 others
What the payments were for
- Food & beverage$1,607100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| E.r. Squibb & Sons, L.L.C. | 27 | $358 |
| Johnson & Johnson | 33 | $308 |
| AstraZeneca | 14 | $187 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 11 | $165 |
| Actelion Pharmaceuticals US, Inc. | 7 | $113 |
| Amarin Pharma, Inc. | 5 | $62 |
| Philips North America LLC | 2 | $60 |
| Abbott | 2 | $45 |
| Pfizer | 2 | $42 |
| Bayer | 2 | $39 |
| Novartis | 2 | $35 |
| United Therapeutics Corporation | 2 | $34 |
| Amgen | 2 | $30 |
| Chiesi USA, Inc. | 2 | $27 |
| Regeneron Healthcare Solutions, Inc. | 1 | $20 |
| Daiichi Sankyo Inc. | 1 | $20 |
| Alnylam Pharmaceuticals Inc. | 1 | $19 |
| Merck | 1 | $16 |
| Abiomed | 1 | $15 |
| Heartflow, Inc. | 1 | $14 |
How this compares
$1,607 in reported general payments places this provider in the 85th percentile of 504 nurse practitioner providers in South Dakota.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 91 | $76,627 |
| Repatha SureclickEvolocumab | 49 | $35,135 |
| XareltoRivaroxaban | 40 | $29,758 |
| Praluent PenAlirocumab | 41 | $24,434 |
| MultaqDronedarone Hcl | 16 | $16,933 |
| Repatha PushtronexEvolocumab | 21 | $12,606 |
| Repatha SyringeEvolocumab | 16 | $8,640 |
| Metoprolol Succinate | 460 | $6,200 |
| Ranolazine ErRanolazine | 87 | $5,989 |
| BrilintaTicagrelor | 14 | $5,917 |
| Rosuvastatin Calcium | 506 | $4,685 |
| Ezetimibe | 204 | $4,553 |
| Flecainide Acetate | 72 | $3,021 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 114 | $2,378 |
| Atorvastatin Calcium | 219 | $2,024 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $42 | $76,62791 claims |
| Johnson & JohnsonXarelto | $308 | $29,75840 claims |
| AstraZenecaBrilinta | $187 | $5,91714 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 504 nurse practitioner providers in South Dakota.
Other nurse practitioner in Sioux Falls
- Jamie BuschSioux Falls$60K
- Jessica SlabaSioux Falls$41K
- Christopher NelsonSioux Falls$35K
- Katherine EricsonSioux Falls$13K
- Gabrielle PriceSioux Falls$5K
- Jacqueline KelleySioux Falls$5K
- Jessica YoshinoSioux Falls$5K
- Catherine McCulleySioux Falls$5K
- Heather MitzelSioux Falls$5K
- Tiffanie VaneimerenSioux Falls$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.